Clinical trial

Raltegravir and Atazanavir Dosing Strategy Study

NCT00874523

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-07-01

PhasePHASE3

Study timeline

Study start (unknown)2009-07-01Date precision: month

Registry last updated2012-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionunresolved

Interventions

atazanavir plus raltegravirDRUG

Sponsors & collaborators

Kirby Institutelead sponsor

Mapped research locations

SydneyNew South Wales, Australia2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00874523 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.